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The impact of study design on the results of medical research has long been an area of both substantial debate and a smaller
body of empirical research. Examples come from many disciplines within clinical and public health research. Among the early
major contributions in the 1970s was work by Mosteller and colleagues (Gilbert et al., 1997), who noted that innovations in surgery
and anesthesia showed greater gains than standard therapy when nonrandomized, controlled trials were evaluated compared with
the gains reported in randomized, controlled trials. More recently, we and others have evaluated the impact of design in medical
and surgical research, and concluded that the mean gain comparing new therapies to established therapies was biased by study
design in nonrandomized trials (Colditz et al., 1989; Miller et al., 1989). Benson and Hartz (2000) conducted a study in which they
focused only on studies reported after 1985. On the basis of 136 reports of 19 diverse treatments, Benson and Hartz concluded
that in only 2 of the 19 analyses did the combined data from the observational studies lie outside the 95% conﬁdence interval
for the combined data from the randomized trials. A similar study drew only on data reported from 1991 to 1995, which showed
remarkably similar results among observational studies and randomized, controlled trials (Concato et al., 2000). These more recent
data suggest that advancing the study design and analytic methods may reduce bias in some evaluations of medical and public
health interventions. Such methods apply not only to the original studies, but also to the approaches that are taken to quantitatively
combine results by using meta-analytic approaches such as random effects meta-regression, Bayesian meta-analysis, and the like
(Normand, 1999). By focusing attention on thorough data analysis, design issues can be understood and their impact or bias can
be estimated, on average, and then ideally accounted for in the interpretation of data.
Before discussing dietary data, let us ﬁrst consider some of the more clearly delineated preventive exposures. Issues of study
designhavebeenaddressedintermsofcombiningrandomizedtrialsandobservationalstudiesinevaluatingpreventiveinterventions
such as Bacillus Calmette-Gu´ erin vaccination (Colditz et al., 1994) and mammography screening (Desmissie et al., 1998). When
one is interpreting the apparent heterogeneity in the results, it is important to step back and ask what is the relationship being
evaluated under these different study designs? For example, a randomized, controlled trial uses the intention-to-treat analysis to
preserve the merit of randomization. Such an analysis does not evaluate the exposure-disease relationship, but rather examines
the impact of offering a new therapy versus an alternative therapy (regardless of adherence to the intervention, or control or
placebo). On the other hand, a case-control study or a prospective cohort study will evaluate the impact of the screening test among
those participants who were screened as compared with those who were never screened. In prevention studies, the design raises
major issues of the timing of the exposure in the natural history of disease and also the adherence to therapy by healthy research
volunteers. Case-control studies of preventive interventions such as screening mammography and prospective population-based
studiesofpapsmearshavecapitalizedonthisvariationintimesincethelastscreentoevaluatetheprotectiveintervalforascreening
test (IARC Work Group, 1986). In contrast, a trial must choose a level of exposure, such as annual mammography screenings
or colon screenings every 10 years with a colonoscopy, regardless of the evolving evidence on the duration of protection after a
negative screening test.
Continuing with the mammography example, a detailed study by Demissie and colleagues (1998) combined data from seven
randomized trials and six case-control studies that investigated the association between participation in breast cancer screening
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programs and breast cancer mortality. The authors showed that if one assumes noncompliance with mammography (approaching
30%) and 20% of the control group is screened, then the beneﬁt of mammography in terms of reduced mortality is comparable
in randomized, controlled trials and epidemiologic studies after adjusting for nonadherence (Demissie et al., 1998). Thus, the
different designs fundamentally measure different constructs of the impact of screening.
Zelen(1988)consideredthechallengesofprimarypreventiontrialsandaddressedbothcomplianceandmodelsofcarcinogenesis
as major impediments to the use of randomized, controlled trials to evaluate cancer prevention strategies. It is important to contrast
these issues in both treatment trials and prevention trials. In treatment trials, recently diagnosed patients, who are often in life-
threatening situations, are typically offered the option to participate in a trial of a new therapy compared with standard therapy
or placebo. Compliance or adherence to therapy is usually very high among these highly motivated patients and their outcomes
are generally in the short- to mid-term. In contrast, prevention trials recruit large numbers of healthy participants, offer them a
therapy, and then follow them over many years because the chronic diseases being prevented are relatively rare. With substantial
noncompliance(oftenintherangeof20%to40%overthedurationofthetrial),anintention-to-treatanalysisisnolongerunbiased,
butrathergivesabiasedestimateoftheeffect,typicallyunderestimatingthemagnitudeoftheassociationthatisseeninobservation
studies in which those participants who have had exposure to a particular lifestyle component are compared with those without
such an exposure.
There are additional challenges for nutritional interventions, including the timing of diet as a preventive agent in the disease
process and the range of nutrient intakes in the population. In retrospective case-control studies, recall bias of past diet is an
additional issue with which to contend. Unlike smoking or screening tests in which the exposure is ﬁnite and can be completely
stopped and started, one’s diet, physical activity, and weight change cannot go to zero for prolonged periods and sustain life.
The range of nutrient intake is a major issue when enrolling participants into prevention trials and observational studies. Health-
conscious volunteers are more often identiﬁed and screened as eligible for a trial.
The epidemiology of diet and colon cancer has been extensively studied. For example, Cho et al. (2004) conducted a combined
analysis of prospective dietary studies of calcium and vitamin D intake data from 10 cohorts. The dose-response relationship
for calcium showed that the greatest beneﬁt for increasing calcium intake was for those participants who had a reported daily
intake below 1000 mg/d. Increasing the intake of those individuals with low intake to the level of 1000 mg/day would yield
a 20% reduction in risk. Beyond this level of intake, there was little additional reduction in the risk of colon cancer. In the
Women’s Health Initiative, participants had a mean calcium intake of 1150 mg/d at baseline and increased this intake in the
intervention arm to 2250 mg/d on average. This magnitude of increase was of limited association in the combined, prospective,
cohort studies and was not related to risk in the randomized trial (Wactawski-Wende et al., 2006). Similar ﬁndings apply to the
interpretation of the vitamin D intervention and highlight the role of dietary intake at randomization when evaluating dietary
components.
Returningtothetimeframeofexposureinthecarcinogenicprocess,thenullrandomized,controlledtrialsofﬁber(Albertsetal.,
2000) and fruit and vegetables (Schatzkin et al., 2000) for the prevention of polyp recurrence amply illustrate Zelen’s concerns
regarding the timing of the preventive intervention in the disease process. The extent of DNA damage accumulated across the
colonic mucosa at the time of detecting the “eligibility polyp” was certainly not limited only to the removed polyp. Rather, these
observations beg the question that at what stage in the disease process may ﬁber play a role in protecting against colon cancer?
This contrasts with the richness of epidemiologic studies that can address exposure over the life course and relate such exposure
to disease risk. Perhaps the best-known example is the radiation follow-up effects cohort in Japan in which a radiation dose was
estimated for each woman who had been exposed to the effects of the atomic bombs on Hiroshima and Nagasaki and followed-up
over 40 years. The results of this study showed a clear and strong relationship between the increased risk of breast cancer with
higher exposure among those participants who were exposed before the age of 20 years (Land et al., 2003).
Retrospectiveassessmentofdietafterdiseasediagnosishasbeendemonstratedtointroducebiasintotheevaluationofexposure-
disease relationships. For example, Giovannucci et al. (1993) evaluated retrospective recall of diet after breast cancer diagnosis
within the ongoing Nurses’ Health Study. In contrast with the prospective analysis in which no relationship between dietary fat and
breast cancer was observed, the retrospective analysis yielded a positive relationship for total fat and saturated fat (Giovannucci
et al., 1993). By comparing the top quintile versus the bottom quintile of reported intake, the retrospective assessment yielded
odds ratios of 1.43 for total fat and 1.38 for saturated fat. Therefore, the magnitude of bias was sufﬁcient to distort evaluation of
the diet-disease relationship.
Prospectivedietarydata,ascollectedinnumerouscohortstudiesthatcontributetothepooledanalysisofdietandchronicdisease,
have the added potential of allowing for consistent approaches to error correction across the participating cohorts (Smith-Warner
et al., 2006). An additional advantage of prospective cohort studies is the potential to obtain unbiased recall from participants who
are free from disease to “ﬁll in” their dietary history from earlier in life. This approach, implemented within the Nurses’ Health
Studies, has allowed the assessment of the high school diet, and validation studies have shown that such adult recall provides a
reasonably valid measure of the adolescent diet (Maruti et al., 2005; Maruti et al., 2006). Given the temporal constraints, such
recall is necessary to evaluate dietary intake in early life in relationship to cancer end points.12 G. A. COLDITZ
Overall,prospectivecohortstudiesofferseveraladvantagesforthestudyoftherelationshipbetweendietanddisease,particularly
when validation studies allow for the consideration of error correction (Rosner et al., 1989; Rosner and Gore, 2001). By using
repeated measures, one can address the timing of exposure in the disease process to determine the mechanism of disease and
prevention. The dose of exposure varies according to current population practices, and changes in diet over time can be related to
disease risk, just as the time since cessation of smoking can be related to disease mortality when one has repeated measures of
cigarette smoking (Kenﬁeld et al., 2008). Although trials for prevention of chronic disease have merit, their interpretation must
be cautioned by the level of participation and the potential that they are addressing an intervention at the wrong point in the
carcinogenic process.
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